Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial

Table 1

Comparison of clinical efficacy of two groups (n (%)).

	Basically cured	Remission	Improved	Invalid	Disease control rate
Group A (n = 39)	3 (7.69)	19 (48.72)	9 (23.08)	8 (20.51)	79.49
Group B (n = 41)	3 (7.32)	7 (17.07)	18 (43.90)	13 (31.71)	68.29

; χ² = 7.36.